The White House April 2 issued a proclamation implementing additional tariffs on certain patented pharmaceutical products and ingredients.
Tariffs
This Costs of Caring report provides a data-driven assessment of the financial realities faced by hospitals and health systems, and underscores why sustainable affordability solutions must address the structural drivers of cost growth rather than focusing narrowly on hospital prices alone.
This report outlines the key trends impacting hospital financial stability in 2025.
The Trump administration announced a trade agreement with the U.K. Dec. 1 on pharmaceuticals that exempts U.K. drug products from Section 232 tariffs. In exchange, the U.K. will increase the net price it pays for new medicines by 25%.
Executive Order 14257 Regulating Imports with a Reciprocal Tariff to Rectify Trade Practices that Contribute to Large and Persistent Annual United States Goods Trade Deficits imposes tariffs on all trading partners.
Executive Order 14257 Regulating Imports with a Reciprocal Tariff to Rectify Trade Practices that Contribute to Large and Persistent Annual United States Goods Trade Deficits imposes tariffs on all trading partners.
This order modifies tariff measures previously imposed pursuant to Executive Order 14195, Imposing Duties to Address the Synthetic Opioid Supply Chain in the People’s Republic of China.
The AHA urged the Department of Commerce Oct. 17 to take a balanced approach to ensuring dependable and affordable access to personal protective equipment, medical consumables and medical equipment as it considers future tariff and trade policy.
Executive Order 14257 Regulating Imports with a Reciprocal Tariff to Rectify Trade Practices that Contribute to Large and Persistent Annual United States Goods Trade Deficits imposes tariffs on all trading partners.
The White House Sept. 5 issued an executive order modifying the scope of reciprocal tariffs announced in April to establish a framework of trade deals with international partners on certain goods such as critical minerals and pharmaceutical products.